Drug Discovery World
JANUARY 9, 2024
Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. The first approvals of RSV vaccines (RSVpreF and RSVpreF3) targeted at infants and older adults mark a significant public health milestone.
Policy Prescription
MARCH 26, 2021
Would you vote for legislation to lower drug prices that would lead to a five percent reduction in pharmaceutical innovation — yet simultaneously create a health system in which all Americans could afford the prescription drugs they need? He reminds us that the vaccines were developed with billions of taxpayer dollars.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Vial
MARCH 1, 2024
Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). billion by 2029. By geographical region, the global CRO services market in 2023 was dominated by North America. As a result, the global CRO market is estimated to grow at a compound annual growth rate (CAGR) of 9.6%
Drug Discovery World
OCTOBER 4, 2022
As one of the exciting fields in the pharmaceutical industry, it’s no surprise that Drug Discovery 2022 will feature sessions on developments in CAR-T and the technologies helping researchers in this field. . The psychedelics medicine market is rising in value, with Data Bridge Market Research predicting it will reach $8 billion by 2029.
FDA Law Blog: Biosimilars
DECEMBER 3, 2023
covered insulin product or vaccine). state pharmaceutical assistance programs). Each phase-in policy allows eligible manufacturers to build up in a stepwise manner to the 10% and 20% applicable discounts by 2029 and 2031, respectively. had Part D expenditures on or before August 16, 2022).
Expert insights. Personalized for you.
173 
Let's personalize your content